As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...
All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA ...
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...
Demand for mental health services remains high, despite long wait lists and a massive shortage of providers. Last week, mental health care startup Two Chairs announced a major expansion to help ...
It’s well known that private equity has been staking its claim in healthcare. Private equity acquisitions of U.S. physician practices increased six fold from 2012 to 2021. A new report reveals ...
PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized over-the ...
The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...
It’s no secret the opioid crisis remains a major public health concern in the United States. It was declared a public health emergency in 2017, and for multiple years following, nationwide ...
About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation ...
The potential Medicaid and Supplemental Nutrition Assistance Program (SNAP) cuts could cause serious economic challenges nationwide, a new report warns. The report was published on Tuesday by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback